Sustainability

ESG Performance Data

Environmental

Management
2015 2016 2017 2018 2019
Group companies with ISO 14001 certification 2 2 2 2 2
Group companies performing environmental audit (internal audit) 3 3 3 3 3
Group companies performing environmental audit (external audit)*1 3 3 3 3 3
Group companies performing environmental audit (audit by H.U. Group)*2 23 20 19 17 16
Employees receiving environmental training*3 5,727※4 5,692 6,030 6,069 5,953
Violations of environmental laws or regulations 0 0 0 0 0
  1. Both internal and external audits performed at SRL and Fujirebio (ALSI)
  2. Audit of waste disposal contractors and environmental measurement contractors of Fujirebio
  3. Total number of employees receiving group-wide environmental training
  4. For SRL, average from April to December
Climate change
Unit 2015 2016 2017 2018 2019
GHG emissions*1
 
 
 		 Scope 1 t-CO2 9,453 9,141 11,221 10,712 11,162
Scope 2 t-CO2 23,464 22,217 24,912 22,822 22,088
Scope 3*2 Purchased goods and services t-CO2 104,676 93,037 112,020 113,338 121,808
Capital Goods t-CO2 33,937 7,794 48,567 57,765 32,303
Fuel-and-energy-related activities
(not included in scope 1 or scope 2)		 t-CO2 5,359
Transportation and delivery
(upstream)		 t-CO2 139,600 101,688 157,605 167,141 153,176
Waste generated in operations t-CO2 3,255 3,519 3,581 3,749 4,168
Business travel t-CO2 747 740 1,566 1,612 1,625
Employee commuting
(including commuting by car)		 t-CO2 1,120 1,063 2,548 2,590 3,940
Upstream leased assets t-CO2 - - - - -
Transportation and delivery
(downstream)*2		 t-CO2 - - - - -
Processing of Sold Products t-CO2 - - - - -
Use of sold products*2 t-CO2 2,929 2,810 2,598 2,676 2,001
End-of-Life Treatment of Sold Products t-CO2 931 854 885 834 759
Leased assets (downstream) t-CO2 5,565 4,317 5,306 5,219 6,264
Franchises t-CO2 - - - - -
Investments t-CO2 - - - - -
Total t-CO2 292,760 215,823 334,676 354,925 331,403
CO2 emissions Scope 1+2 t-CO2 32,917 31,358 36,133 33,534 33,250
CO2 emission intensity Scope 1+2 t-CO2 / ¥100 million
(sales)		 26.0 25.0 23.3 21.0 19.9
NOx emissions*3 t
SOx emissions*3 t
VOC emissions*3 t
Emissions of ozone-depleting substances (ODS)*4
Energy intensity (converted to crude oil) kL / ¥100 million
(sales)		 12.1 12.2 11.5 10.7 10.2
Consumption rate by energy type*5 Renewables
(converted to crude oil or calories)		 % 0 0 0 0 0
Fuel % 26 26 28 28 28
Electricity % 74 74 72 72 72
Carbon offset*3
Energy Use*5 Electricity kL
(converted to crude oil)		 11,282 11,246 12,901 12,363 12,170
City gas kL
(converted to crude oil)		 1,613 2,070 2,335 2,176 2,097
LPG (propane gas) kL
(converted to crude oil)		 456 1 60 59 74
Gasoline kL
(converted to crude oil)		 1,781 1,704 2,246 2,235 2,391
Kerosene kL
(converted to crude oil)		 177 209 190 167 187
Heavy oil kL
(converted to crude oil)		 21 17 68 68 65
Light oil kL
(converted to crude oil)		 5 3 3
Renewable energy 0 0 0 0 0
Total 15,330 15,248 17,805 17,072 16,987
CDP climate change score*6 F F F F C
  1. Based on Japan’s Ministry of the Environment’s emission source unit database (ver. 2.5) for calculating green gas emissions through the supply chain (March 2018)
  2. Based on Scope3 Items of GHG Protocol, we calculate the items targeted.)
  3. Data currently unavailable
  4. Not used
  5. Calculated as a crude oil conversion value
  6. Answered for the first time in FY 2019
Waste
Units 2015 2016 2017 2018 2019
Waste output per sales*1 t / ¥100 million (sales) 1.8 1.8 2.2 2.2 2.1
Amount of waste generated t 2,288 2,307 3,467 3,581 3,494
Breakdown of waste generated General waste t 473 366 665 632 654
Industrial waste t 1,070 1,127 2,016 2,105 1,866
Specially controlled industrial waste t 745 814 786 844 973
Recycling rate*2 % 97.0 90.7 84.0 83.0 86.0
Emissions of PRTR Law Class I Designated Chemical Substances*3 t 3.6 4.2 3.9 3.0 3.9
  1. Divided by sales amount
  2. For Fujirebio and Care'x
  3. For Fujirebio
Water
Units 2015 2016 2017 2018 2019
Water used Thousand m3 229 223 392 374 399
Waste water Thousand m3 219 213 383 367 375
Waste water per sales*1 Thousand m3 / ¥100 million
(sales)		 0.17 0.17 0.25 0.23 0.22
COD (chemical oxygen demand)*2 t 0.2 0.3 0.4 0.4 0.5
  1. Divided by sales amount
  2. Total for Fujirebio only

Social

Customers
2015 2016 2017 2018 2019
Rate of participation in control survey and quality control reporting at medical institutions using the LUMIPULSE system 91% 89% 85% 90% 88%
Number of voluntarily recall incidents In Vitro Diagnostics business*1 0 1 0 0 0
Number of serious nonconformities In Vitro Diagnostics business*1 0 1 0 0 0
Clinical Laboratory Testing business*2 1 1 1 1 0
  1. Voluntary recall incidents defined as serious nonconformities
  2. Cases requiring administrative response
Business partners
2015 2016 2017 2018 2019
Number of suppliers performing risk assessment*1 89
Percentage of suppliers performing risk assessment*1 100%
Reported cases of child labor at suppliers 0 0 0 0 0
Reported cases of forced labor at suppliers 0 0 0 0 0
  1. Suppliers at 80% sales coverage of each of the applicable range
Employees
2015 2016 2017 2018 2019
Number of employees Regular employees (female)*1 1,034 1,039 1,245 1,260 1,940
Regular employees (male)*1 1,618 1,562 1,844 1,975 2,261
Managers (female)*1, 2 23 21 50 66 74
Managers (male)*1, 2 237 215 334 401 458
Directors and Officers*3 26 20 20 22 33
Number of employees by area*1 Japan (female) 1,056 1,059 1,294 1,326 2,013
Japan (male) 1,846 1,766 2,169 1,966 2,713
Asia (female) 1 1 1 1 1
Asia (male) 6 6 4 5 5
North America (female) 0 0 0 0 0
North America (male) 3 3 4 1 1
Europe (female) 0 0 0 0 0
Europe (male) 0 2 1 1 0
Average age*3 43.9 44.6 42.9 42.5 40.0
Number of women employees in new hires*1 Male 10 21 25 59 41
Female 16 32 34 99 95
Average employment year*3 Male 14.2 14.3 13.0
Female 10.6 11.1 10.0
Percentage difference 3.6 3.2 3.0
Annual working hours per employee*3 2,054 2,001 2,015 2,034 2,008
Average days of paid leave taken*3 8 8 7 8 12
Average rate of paid leave taken*3 42.5% 44.5% 43.4% 44.0% 60.1%
Work-related deaths*1 0 0 0 0 0
Lost time injury frequency rate*1 0.00% 0.19% 0.35% 0.27% 0.75%
Percentage of female managers*1, 2 9.4% 10.0% 11.8% 14.1% 14.2%
Percentage of female new recruits incl. mid-career employment*1 48.4% 40.5% 43.4% 49.1% 46.3%
Average years of employment (years / employee)*3 16.7 17.2 16.5 13.0 12.0
Under age 30 2.5 2.7 2.7 1.6 2.0
Age 30 to 50 14.6 14.9 15.0 10.7 10.0
Age 50 and over 24.4 24.5 24.7 23.2 22.0
Employees with disabilities*1 75 77 67 66 161
Percentage of employees with disabilities*1 2.20% 2.20% 2.01% 1.97% 1.86%
Foreign-national employees*3 10 10 14 16 13
Employees taking parental leave (including paternity leave)*3 43 66 66 84 173
Percentage of employees taking parental leave (including paternity leave)*3 95.3% 98.1% 98.1% 100.0% 100.0%
Percentage of employees returning to work after maternity / parental leave*3 97.2% 100% 100% 90.6% 97.0%
Employees taking family care leave (short term)*3 10 36 24 21 3
Employees taking family care leave (long term)*3 1 2 3 3 3
Average annual salary of employees*3 7,679,456 7,307,152 7,387,697 6,791,909 5,713,090
Employee turnover rate*3 5.3% 5.7% 6.2% 5.0% 6.1%
Percentage of employees undergoing medical checkup*3 94.3% 94.4% 92.7% 94.9% 92.3%
Average annual training time per employee 11 8
Employees passing DMR qualification exam*1 5 1 7 28 28
Participants in human error prevention courses*1 35 32 44 41 75
Average monthly overtime hours*3 19.5 17.8 21.5 19.0 21.0
  1. For the 3 companies
  2. Managers & above
  3. Full-time employees
Community
2015 2016 2017 2018 2019
Participants in philanthropic activities*1 300 300 300 1,514 459
Participants in H.U. Group Summer Festival Over 2,000 Over 2,000 Over 2,000 Over 2,000 Over 2,000
Charitable trust fund*2 Research subsidies
(JPY)		 209,800,000 214,800,000 219,800,000 224,800,000 229,800,000
Koichiro Fujita Award
(JPY)		 6,000,000 6,500,000 7,000,000 7,500,000 8,000,000
Nozomu Kosakai Award
(JPY)		 13,000,000 13,500,000 14,000,000 14,500,000 15,000,000
Seminars held in China 12 30 Over 100 Over 100 Over 100
Marrow donor program (No. of cases) 9,458 8,801 8,363 9,244 9,512
  1. Full-scale operation since FY2018. Lower estimate up to FY2017.
  2. Cumulative amount for each category
Shareholders
2015 2016 2017 2018 2019
Shareholder / investor Engagement 292 325 303 219 159

Governance

Compliance
2015 2016 2017 2018 2019
Violations of anti-corruption policies and procedures 0 0 0 0 0
Fines for violations stated above 0 0 0 0 0
Percentage of employees taking compliance comprehension test 97.3% 99.0% 95.4% 94.5%
Inquiries to IT Service Desk*1 9,531 18,251 12,353
Cases reported to H.U. Group Hotline 36 59 104 109 125
  1. Established in FY2017

Applicable range/period

Applicable range 　
Environment:
we have aggregated the results of the three major companies in FY 2015 and 2016, and we dislosed the results of six domestic companies subject to internal control from 2017.
　
3 companies:
H.U. Group Holdings, Inc., SRL, Inc. and Fujirebio, Inc.
　
6 companies:
H.U. Group Holdings, Inc., SRL, Inc., Fujirebio, Inc., NIHON STERY CO., LTD.,
Japan Clinical Laboratories, Inc. and Care'x, Inc.
Period Those figures are calculated based on our fiscal year.
(April 1 to March 31 of the following year) (Except where noted)